Wave Life Sciences Ltd.

Historical 13F Holders

Symbol
WVE
CUSIP
Y95308105
All holders as of
Q3 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for Y95308105 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
17.1% 4/17/2026
Event 4/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
FMR LLC 13G/A
2.8% 5/6/2026
Event 3/31/2026
Adage Capital Management, L.P. 13G/A
0.5% 5/13/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 0% 10/27/2026
Event 9/30/2026
Maverick Capital, Ltd. 13G/A
0% 11/16/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 4 793 k $3.09M
2026 Q2 242 182 M $1.06B
2026 Q1 236 173 M $1.25B
2025 Q4 222 183 M $3.11B
2025 Q3 193 144 M $1.05B
2025 Q2 180 139 M $903M
2025 Q1 200 131 M $1.06B
2024 Q4 186 129 M $1.59B
2024 Q3 165 120 M $986M
2024 Q2 145 95.1 M $474M
2024 Q1 134 92.8 M $572M
2023 Q4 116 92.5 M $468M
2023 Q3 86 72.6 M $417M
2023 Q2 82 72.2 M $263M
2023 Q1 74 70.1 M $303M
2022 Q4 76 68.1 M $477M
2022 Q3 63 67.3 M $243M
2022 Q2 63 67.8 M $220M
2022 Q1 85 47.7 M $95.4M
2021 Q4 93 47.3 M $149M
2021 Q3 90 37.4 M $184M
2021 Q2 90 37.0 M $247M
2021 Q1 105 38.3 M $215M
2020 Q4 112 36.1 M $284M
2020 Q3 113 37.1 M $316M
2020 Q2 96 29.4 M $306M
2020 Q1 80 30.1 M $282M
2019 Q4 100 29.5 M $236M
2019 Q3 89 30.9 M $634M
2019 Q2 104 30.5 M $795M
2019 Q1 115 29.4 M $1.14B
2018 Q4 93 24.4 M $1.03B
2018 Q3 93 23.9 M $1.19B
2018 Q2 78 24.6 M $940M
2018 Q1 79 23.7 M $949M
2017 Q4 73 22.2 M $780M
2017 Q3 58 20.5 M $446M
2017 Q2 56 19.3 M $359M
2017 Q1 49 15.7 M $432M
2016 Q4 51 14.8 M $388M
2016 Q3 46 14.1 M $457M
2016 Q2 39 14.2 M $294M
2016 Q1 23 14.0 M $192M
2015 Q4 19 13.8 M $219M